Covista Inc. Q1 2027 Earnings Recap

Covista’s stock fell 3.5% despite the company raising its fiscal 27 revenue and adjusted EPS guidance. The likely concern is that the outlook remains deliberately cautious for the remaining quarters, leaving investors unconvinced by the quarter’s above-plan performance.

Key Takeaways

• Q1 revenue rose 10.7% to $512 million; adjusted EBITDA increased 17.1% to $131 million, and adjusted EPS grew 25.1% to $2.19.
• Total enrollment reached nearly 105,000, up 7.6% year over year, marking the 13th consecutive quarter of growth.
• Management raised fiscal 27 revenue and adjusted EPS guidance, while saying it is taking a prudent view of the remaining quarters.
• Chamberlain enrollment grew 1.3%, its third consecutive quarter of growth; Walden posted double-digit enrollment growth for the 10th straight quarter, with undergraduate enrollment up more than 20%.
• In medical and veterinary, enrollment rose 3.5%. Management said early starts ahead of federal loan changes lifted the May cycle and made the September class smaller, so it views the two cycles together.